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Summary
Background Extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC), plasmid-mediated AmpC-
producing E coli (pAmpC-EC), and other bacteria are resistant to important β-lactam antibiotics. ESBL-EC and 
pAmpC-EC are increasingly reported in animals, food, the environment, and community-acquired and health-care-
associated human infections. These infections are usually preceded by asymptomatic carriage, for which attributions 
to animal, food, environmental, and human sources remain unquantified.
Methods In this population-based modelling study, we collected ESBL and pAmpC gene data on the Netherlands 
population for 2005–17 from published datasets of gene occurrences in E coli isolates from different sources, and 
from partners of the ESBL Attribution Consortium and the Dutch National Antimicrobial Surveillance System. Using 
these data, we applied an established source attribution model based on ESBL-EC and pAmpC-EC prevalence and 
gene data for humans, including high-risk populations (ie, returning travellers, clinical patients, farmers), farm 
and companion animals, food, surface freshwater, and wild birds, and human exposure data, to quantify the overall 
and gene-specific attributable sources of community-acquired ESBL-EC and pAmpC-EC intestinal carriage. We also 
used a simple transmission model to determine the basic reproduction number (R0) in the open community.
Findings We identified 1220 occurrences of ESBL-EC and pAmpC-EC genes in humans, of which 478 were in clinical 
patients, 454 were from asymptomatic carriers in the open community, 103 were in poultry and pig farmers, and 
185 were in people who had travelled out of the region. We also identified 6275 occurrences in non-human sources, 
including 479 in companion animals, 4026 in farm animals, 66 in wild birds, 1430 from food products, and 274 from 
surface freshwater. Most community-acquired ESBL-EC and pAmpC-EC carriage was attributed to human-to-human 
transmission within or between households in the open community (60·1%, 95% credible interval 40·0–73·5), and 
to secondary transmission from high-risk groups (6·9%, 4·1–9·2). Food accounted for 18·9% (7·0–38·3) of carriage, 
companion animals for 7·9% (1·4–19·9), farm animals (non-occupational contact) for 3·6% (0·6–9·9), and 
swimming in freshwater and wild birds (ie, environmental contact) for 2·6% (0·2–8·7). We derived an R0 of 0·63 
(95% CI 0·42–0·77) for intracommunity transmission.
Interpretation Although humans are the main source of community-acquired ESBL-EC and pAmpC-EC carriage, the 
attributable non-human sources underpin the need for longitudinal studies and continuous monitoring, because 
intracommunity ESBL-EC and pAmpC-EC spread alone is unlikely to be self-maintaining without transmission to 
and from non-human sources.
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Introduction
Extended-spectrum β-lactamase (ESBL)-producing 
Escherichia coli (ESBL-EC) and plasmid-mediated AmpC 
(pAmpC)-producing E coli (pAmpC-EC) are important 
causes of treatment failure with β-lactam antibiotics, 
which include widely used antibiotics of critical 
importance for human therapy. ESBLs and pAmpCs 
are a public health concern because these enzymes 
render bacteria non-susceptible to third-generation 
cephalosporins, resulting in increased use of last-resort 
antibiotics like carbapenems.1 Historically, ESBL-EC and 
pAmpC-EC infections have been associated with health-
care settings,2 but their acquisition in the community has 
been increasingly reported in several countries since 
2000–10.3 Although a high prevalence of ESBL-EC and 
pAmpC-EC has been reported in livestock (particularly 
poultry),4 chicken meat,2 and companion animals,5 their 
role as sources of human infection with ESBL-EC and 
Lancet Planet Health 2019: 
3: 357–69
This online publication has 
been corrected. The corrected 
version first appeared at 
thelancet.com/planetary-
health on September 4, 2019
*Contributed equally
National Institute for Public 
Health and the Environment 
(RIVM), Centre for Infectious 
Disease Control (CIb), 
Bilthoven, Netherlands 
(L Mughini-Gras PhD, 
E van Duijkeren PhD, 
C M Dierikx PhD, H Schmitt PhD, 
E G Evers PhD, W van Pelt PhD, 
E Franz PhD); Institute for Risk 
Assessment Sciences 
(L Mughini-Gras, 
A Dorado-García PhD, H Schmitt, 
Prof D J J Heederik PhD) and 
Department of Infectious 
Diseases and Immunology 
(Prof D J Mevius PhD), Utrecht 
University, Utrecht, 
Netherlands; Department of 
Medical Microbiology 
(Prof M J M Bonten PhD), Julius 
Centre for Health Sciences and 
Primary Care 
(G van den Bunt MSc, 
M C J Bootsma PhD), University 
Medical Centre Utrecht 
(UMCU), Utrecht, Netherlands; 
Technical University of 
Denmark, National Food 
Institute, Lyngby, Denmark 
(Prof T Hald PhD); and 
Wageningen Bioveterinary 
Research (WBVR), Lelystad, 
Netherlands (A de Koeijer PhD, 
Prof D J Mevius)
Correspondence to: 
Dr Lapo Mughini-Gras, National 
Institute for Public Health and 
the Environment (RIVM), 
Centre for Infectious Disease 
Control (CIb), PO Box 1, 
3720 BA Bilthoven, Netherlands 
lapo.mughini.gras@rivm.nl
Articles
e358 www.thelancet.com/planetary-health   Vol 3   August 2019
pAmpC-EC remains controversial.2,6,7 Human exposure 
to ESBL-EC and pAmpC-EC might occur via animals, 
food, the environment, and human-to-human trans-
mission; however, their relative contributions are yet to 
be quantified.
Cross-sectional studies in the Netherlands report 
a prevalence of approximately 5% for ESBL-EC and 
pAmpC-EC intestinal carriage in the open community.8–12 
Because ESBL-EC and pAmpC-EC human infections are 
often preceded by asymptomatic carriage,13 a crucial step 
towards breaking the transmission chain is to identify 
their sources. Here, we applied an established source 
attribution model based on nationally representative 
ESBL-EC and pAmpC-EC gene, prevalence, and human 
exposure data to quantify the relative contributions of 
several sources to community-acquired ESBL-EC and 
pAmpC-EC intestinal carriage in the Netherlands.
Methods
Study design and data collection
In this population-based modelling study, we collected 
data on ESBL and pAmpC gene occurrences in E coli 
isolates in the Netherlands for 2005–17. We used a 
published dataset containing ESBL and pAmpC gene 
occurrences among 5808 E coli isolates from different 
sources.7 This dataset, which was derived from 35 studies, 
comprises over 27 000 samples; full details of these 
studies have been reported previously.7 Briefly, peer-
reviewed publications reporting ESBL and pAmpC 
gene data in the Netherlands during 2000–15 were 
Research in context
Evidence before this study
Bacteria that produce extended-spectrum β-lactamase (ESBL) 
and plasmid-mediated AmpC (pAmpC) enzymes can inactivate 
important antibiotics, such as cephalosporins and 
monobactams, which then lose their efficacy. Occurrence of 
ESBLs and pAmpCs is the result of several factors, including 
antibiotic use or misuse in humans and animals, which 
promotes ESBL and pAmpC selection and transmission in 
bacterial populations, and human factors such as mobility of 
people and trade of goods, as well as environmental 
contamination. Human exposure to ESBLs and pAmpCs can 
occur via animals, food, the environment, and human-to-
human transmission. However, the relative contributions of 
these transmission routes are unknown. Source attribution 
methods have been widely used for foodborne pathogens, 
allowing the identification of the main sources of human 
infections. These findings have proven crucial for the 
development of effective public health interventions. 
For antimicrobial resistance, few comprehensive microbial 
subtyping datasets for different sources are available—a 
cornerstone of some of these methods—preventing their 
routine application. We did a PubMed search, with no language 
restrictions, for articles published between database inception 
and Jan 1, 2019, using the search terms “source attribution” and 
“antimicrobial resistance”, from which we identified only six 
relevant publications that used microbial subtyping data or 
exposure assessments for multiple sources of ESBLs and 
pAmpCs. Despite recognition of the importance of source 
attribution for foodborne pathogens and the growing use of 
these approaches, source attribution of antimicrobial resistance 
as such is still in its infancy. Three of six publications referred to 
antimicrobial susceptibility patterns as a typing method for 
Salmonella source attribution but did not focus on the sources 
of specific resistance genes. Two comparative exposure 
assessments were restricted to estimating the relative 
contributions of different types of meat to ESBLs and AmpCs in 
humans. Only one study described similarities in ESBL and 
pAmpC genes among different sources.
Added value of this study
So far, statements regarding prioritisation of interventions 
targeting the sources of community-acquired carriage of ESBL-
producing and pAmpC-producing Escherichia coli have been 
based on prevalence and similarities in microbial typing data for 
only a few sources at once. To our knowledge, this is the first 
study to quantitatively estimate attributions for ESBLs and 
AmpCs, derived from modelling of large datasets for multiple 
animal, food, environmental, and human sources. Our analysis 
provides quantitative links between specific ESBL and pAmpC 
genes in E coli and their human and non-human sources, and 
shows that most community-acquired carriage of ESBL-
producing and pAmpC-producing E coli is attributable to 
human-to-human transmission, followed by food, animal, and 
environmental sources. Deriving a basic reproduction number 
also showed that although humans are the main source of 
community-acquired carriage of ESBL-producing and pAmpC-
producing E coli, human-to-human transmission within the 
open community alone might not be self-maintaining without 
transmission to and from non-human sources.
Implications of all the available evidence
Our study shows the complex links of ESBL-producing and 
pAmpC-producing E coli among humans, animal sources, 
the food chain, and the environment. Because humans are 
estimated to be the most important source in the open 
community, hygiene and responsible use of antibiotics in 
health care and veterinary medicine remain important pillars of 
prevention. Although the direct contributions of animals, food, 
and surface freshwater were estimated to be smaller, they entail 
large reservoirs of infection, contamination, and dissemination 
of ESBLs and pAmpCs to which humans remain continuously 
exposed and subsequently contribute to further spread of ESBLs 
and pAmpCs among individuals. Therefore, continuous 
monitoring of antimicrobial resistance in humans, animals, and 
other sources is crucial to detect changes in trends and 
dynamics, underpinning the need for longitudinal studies, 
because carriage of ESBLs and pAmpCs is temporal and the 
importance of some sources might fluctuate over time.
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systematically reviewed and studies were included only if 
they examined E coli with data for ESBL genes of CTX-M, 
TEM, or SHV families, with restrictions on whether the 
studies were in humans or non-humans (full details of 
the eligibility criteria have been reported previously).7 
Partners of the ESBL Attribution (ESBLAT) Consortium12 
and the Dutch National Antimicrobial Surveillance 
System (MARAN) provided additional data. For this 
study, additional ESBL-EC and pAmpC-EC gene data for 
2016–17 were included from the ESBLAT Consortium 
and MARAN. We categorised frequencies of ESBL genes 
of the CTX-M, TEM, or SHV families associated with 
phenotype 2be,14 and frequencies of pAmpC genes of the 
CMY, ACC, ACT, MIR, or DHA families by source. 
Because multiple gene occurrences in the same isolate 
are rare, we arranged them in a mutually exclusive way.
For occurrences of ESBL-EC and pAmpC-EC genes in 
humans, those in patients with clinical ESBL-EC or 
pAmpC-EC infections or requiring admission to hospital 
or stay in long-term care facilities, or both, in the past 
12 months for any cause were considered as being from a 
high-risk group (according to the most common ESBL-
EC and pAmpC-EC carriage persistence period in health-
care-associated and clinically infected indivi duals15,16) and 
separated from those identified in the samples of 
asymptomatic individuals in the open community—ie, 
carriers. Other high-risk groups were farmers 
occupationally exposed to poultry and pigs17 and people 
who had returned from travelling to Africa, Asia, or South 
or Central America in the past 4 weeks (defined according 
to destinations posing an increased risk for ESBL-EC and 
pAmpC-EC carriage and the most common period for 
carriage persistence among Dutch travellers10,18). Hence, 
the open community was defined as any individual who 
had not travelled to these regions in the past 4 weeks, who 
had not had a clinical infection caused by ECBL-EC or 
pAmpC-EC or another health condition requiring medical 
attention in the past 12 months, and who had not engaged 
in farming activities involving direct occupational contact 
with poultry or pigs.
We also identified several non-human sources of ESBL-
EC and pAmpC-EC gene occurrences and the number of 
samples that were positive and negative for ESBL-EC and 
pAmpC-EC in these sources: companion animals (ie, 
dogs, cats, horses), farm animals (ie, cattle, pigs, chickens, 
and sheep and goats), wild birds, meat products (ie, 
chicken meat, turkey meat, bovine meat, pork, and sheep 
and goat meat), raw vegetables, seafood, and surface 
freshwater (appendix pp 1–4). The magnitude of exposure 
of the open community to each of these sources was 
derived from five large population-based studies in the 
Netherlands.10,12,19–21 For food sources, exposure was 
defined as the probability of a person in the open 
community having consumed these products at least 
once in the past 4 weeks. For farm and companion 
animals, exposure was defined as the probability of a 
person in the open community having non-occupational 
(hobby or recreational) direct contact with these animals 
at least once in the past 4 weeks. For wild birds, exposure 
was more generally defined as touching or feeding wild 
birds, cleaning bird feeders or other areas covered with 
bird droppings, collecting bird feathers, or contact with a 
dead bird at least once in the past 4 weeks. For surface 
freshwater, exposure was defined as the probability of a 
person in the open community having had direct contact 
with surface freshwater through swimming at least once 
in the past 4 weeks. For human sources (high-risk 
groups), exposure was defined as the probability of a 
person in the open community encountering a traveller 
who returned from Africa, Asia, or South or Central 
America fewer than 4 weeks ago; an individual who had a 
clinical infection caused by ESBL-EC or pAmpC-EC, or 
another health conditions requiring medical attention (ie, 
exposed to health-care settings, including hospitals and 
long-term care facilities) in the past 12 months; or a 
person who had been engaged in farming activities 
entailing occupational direct contact with poultry and 
pigs in the past 4 weeks. Inversely proportional to the 
exposure to high-risk groups, the exposure to the open 
community was defined as the probability of an individual 
belonging to the open community having encountered 
another individual in the same population. Input 
parameters and data origins are in the appendix (pp 3–4).
Data analysis
We used a commonly applied source attribution model 
for pathogens based on typing data, the modified 
Hald model,22 with some adaptations for our study 
compared with its previous applications, for example, for 
Salmonella,22,23 Campylobacter,22 Listeria,24 and Shiga toxin-
producing E coli.25 Our analysis was based on ESBL-EC 
and pAmpC-EC genes in the open community as the 
group to be attributed to the aforementioned human and 
non-human sources. Additionally, because ESBL-EC and 
pAmpC-EC transmission also occurs among people,16,18 
the open community was also set as a potential source of 
ESBL-EC and pAmpC-EC for the open community itself.
The model assumes that the observed frequency of 
ESBL-EC or pAmpC-EC gene i (with i = 1–41) in the open 
community, denoted as oi, is given by
with λij being the expected frequency of gene i from 
source j (with j = 1–20), estimated as
where pij is the prevalence of gene i in source j, given by 
πj × rij, with πj being the overall ESBL-EC and pAmpC-EC 
prevalence in source j, and rij being the relative frequency 
of gene i in source j. qi is the gene-dependent factor, 
which accounts for differences in the success (ie, fitness) 
of E coli carrying ESBL or pAmpC gene i to colonise 
oi ~ poisson (∑j λij)
λij = pij × mj × qi × aj
See Online for appendix
Articles
e360 www.thelancet.com/planetary-health   Vol 3   August 2019
individuals in the open community (eg, persistence, 
virulence), and aj is the source-dependent factor, 
which accounts for the ability of source j to act as a 
vehicle for ESBL-EC and pAmpC-EC (eg, differences 
in bacterial concentration, source characteristics 
influencing bacterial growth and survival, preparation 
and handling procedures, and differences in sensitivity 
and randomness of sampling between studies). Both qi 
and aj are unknown and therefore fitted by the model on 
specification of uninformative priors (appendix pp 3–4). 
mj is the exposure weight, a scaling factor for aj that 
accounts for the magnitude of exposure to each source j 
in the open community—ie, the proportion of individuals 
directly exposed to each source. Details of model 
parameterisation are in the appendix (pp 3–4). We 
obtained posterior distributions using a Markov Chain 
Monte Carlo simulation. Five independent Markov 
chains were run for 50 000 iterations after a burn-in 
period (ie, omission of iterations at the beginning of the 
simulation to minimise the effect of the initial values on 
the posterior estimates) of 10 000 iterations, which was 
able to provide convergence according to Gelman-
Rubin’s method.26
We identified which genes were present only in the 
open community, which were only in sources (ie, high-
risk humans, food, animals, and environment), and 
which were present both in the open community and the 
sources. Genes only found in sources were kept in the 
model to preserve the within-source gene relative 
frequencies, as advised in previous studies.22,25
To test our primary results, we did several validation 
analyses. The model uses the similarities of ESBL-EC 
and pAmpC-EC gene frequencies as anchor points for 
attribution, using prevalence and human exposure data 
as scaling factors and qi and aj to account for differential 
gene-specific and source-specific transmission 
efficiencies. By letting the open community be both the 
target and one of the sources, we introduced a strong 
human-to-human linkage in gene frequencies. Although 
such linkages are factual (ie, two human carriers are 
more likely to carry the same ESBL-EC or pAmpC-EC 
gene than, for example, a human and a chicken), 
we checked whether such linkages influenced the 
attributions in a way that would mainly reflect gene 
resemblances using an independent dataset in which 
the true situation was known. We applied our model to 
non-typhoid Salmonella serotyping data from a previous 
Dutch study,23 including humans as a potential source. 
Humans are not an important source of non-typhoid 
salmonellosis because this infection is zoonotic in 
nature, generally short-lived, and has almost no 
asymptomatic carriage (prevalence of 0·05% in a 2016 
Dutch study).27 By knowing a priori that humans do not 
contribute substantially to non-typhoid salmonellosis, we 
checked whether our model reflected this low attribution.
Our model provided attribution estimates only to 
potential sources of direct transmission for the open 
community—ie, we quantified only the last step of the 
transmission chain. Therefore, all sources were treated 
as routes of direct transmission, not as reservoirs per se. 
Indeed, in each source, differential growth, fade, or 
persistence of E coli is possible, so selection leads to 
distinctive ESBL-EC and pAmpC-EC gene profiles, with 
prevalence and human exposure differing too, which 
render these sources quite different from one another. 
Yet, food sources could be argued to be just vehicles of 
most of the ESBL-EC and pAmpC-EC of their respective 
animal reservoirs from which food is contaminated (eg, 
chickens and chicken meat), similarly for surface water 
and human and animal faeces. Because human groups, 
food, animals, and environmental sources were included 
as separate sources, the model treated them indepen-
dently, which might introduce uncertainty if they are 
difficult to distinguish between. Therefore, for com-
parison purposes, we also applied an alternative model 
with the corresponding animal-food sources grouped 
together. Moreover, because swimming in surface 
freshwater occurs almost exclusively during the warm 
season, whereas exposure to the other sources is not as 
seasonal, we did an additional source attribution analysis 
considering only the summer period (June–August).
We used a simple transmission model to determine the 
basic reproduction number (R0) in the open community, 
considering a 5% equilibrium prevalence of community-
acquired ESBL-EC and pAmpC-EC, with and without 
assuming random mixing (eg, the household clustering 
effect; appendix pp 7–10).8–12
Posterior quantities of interest from the Markov Chain 
Monte Carlo simulation were mean values and 95% 
Bayesian credible intervals (CrIs) of percent attributions. 
We also report SDs and median values of the posterior 
distribution. We used 95% CIs as the measure of 
precision for R0.
We used OpenBUGS 3.2 for the Markov Chain Monte 
Carlo simulation and R and Microsoft Excel for data 
storage, statistical calculations, and graphics.
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had 
full access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
The frequencies of ESBL-EC and pAmpC-EC genes in 
the Netherlands for 2005–17 are shown in figure 1 and 
the appendix (pp 1–2). We identified 1220 occurrences of 
ESBL-EC and pAmpC-EC genes in humans, of which 
478 were in clinical patients, 454 were in carriers in the 
open community, 103 were in poultry and pig farmers, 
and 185 were in people who had travelled out of the 
region. We identified 6275 occurrences of ESBL-EC and 
pAmpC-EC genes in non-human sources, of which 479 
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were from companion animals (n=312 dogs, n=48 cats, 
and n=119 horses); 4026 from farm animals (n=2254 
cattle, n=474 pigs, n=1278 chickens, and n=20 sheep and 
goats); 66 from wild birds; 1308 from meat products 
(n=862 chicken meat, n=52 turkey meat, n=302 bovine 
meat, n=75 pork, and n=17 sheep and goat meat); 51 from 
raw vegetables; 71 from seafood; and 274 from surface 
freshwater (figure 1; appendix pp 1–2). For all sources, 
the number of ESBL-positive or pAmpC-positive samples 
in which these genes occurred is shown in the appendix 
(pp 1–2) and is slightly smaller or equal to the number of 
genes. Figure 2 shows the posterior distributions of 
ESBL-EC and pAmpC-EC prevalence of, and human 
exposure to, each source. The final dataset comprised 
7495 ESBL and pAmpC gene occurrences belonging to 
41 different ESBL and pAmpC genes, 17 of which were 
found in the open community and in at least one of the 
sources, whereas the other genes were only found in 
sources.
Attribution estimates are reported in the table. The 
ESBL-EC and pAmpC-EC carriers in the open 
community were estimated to be the primary source of 
ESBL-EC and pAmpC-EC carriage in the open 
community itself (60·1%, 95% CrI 40·0–73·5). 
Secondary transmission from high-risk groups 
accounted for 6·9% (4·1–9·2) of community-acquired 
Figure 1: Frequencies of ESBL-encoding and pAmpC-encoding genes detected in Escherichia coli isolates from human and non-human sources in the 
Netherlands, 2005–17
Heat map shows the relative frequencies of ESBL and pAmpC genes occurring in the E coli isolates from each source. These data are also reported in extended format in 
the appendix (pp 1–2). Retuning travellers are defined as having travelled to Africa, Asia, or South or Central America in the past 4 weeks; clinical patients as having an 
ESBL-producing or pAmpC-producing E coli infection or having been admitted to hospital or a long-term care facility, or both, for any reason during the past 12 months; 
and farmers as people who work occupationally with pigs or poultry. ESBL=extended-spectrum β-lactamase. pAmpC=plasmid-mediated AmpC.
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carriage of ESBL-EC and pAmpC-EC. Food sources 
accounted for 18·9% (7·0–38·3) of community-acquired 
carriage of ESBL-EC and pAmpC-EC (table). Non-
occupational (ie, hobby or recreational) contact with 
farm animals accounted for 3·6% (0·6–9·9) and 
companion animals accounted for 7·9% (1·4–19·9) of 
community-acquired carriage of ESBL-EC and pAmpC-
EC. Swimming in surface freshwater and contact with 
wild birds accounted for 2·6% (0·2–8·7) of community-
acquired carriage of ESBL-EC and pAmpC-EC. In 
100 50
ESBL-EC and pAmpC-EC prevalence (%) Human exposure (%)
0 50 100
Animals
Food
Environment
High-risk groups
Open community
Surface freshwater
Wild birds
Chicken meat
Bovine meat
Sheep and goat meat
Pork
Turkey meat
Seafood
Raw vegetables
Chickens
Cattle
Sheep and goats
Pigs
Dogs
Cats
Horses
Clinical patients
Returning travellers
Farmers
Figure 2: Prevalence of ESBL-EC and pAmpC-EC isolates in each source and probability of exposure of the open community to each source
Error bars are 95% credible intervals. ESBL-EC=extended-spectrum β-lactamase-producing Escherichia coli. pAmpC-EC=plasmid-mediated AmpC-producing E coli.
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summer, swimming in surface freshwater accounted 
for 5·7% (0·2–19·7) of community-acquired carriage 
(appendix pp 11–12).
ESBL and pAmpC gene-specific attributions are shown 
in figures 3 and 4. Of the ESBL-EC and pAmpC-EC genes 
with more than 20 occurrences in the open community 
(appendix pp 1–2), CTX-M-15, CTX-M-14, and CTX-M-27 
were strongly associated with human-to-human 
transmission, with 70% of CTX-M-15 occurrences, 
83% of CTX-M-14 occurrences, and 84% of CTX-M-27 
occurrences being attributed to the carriers in the open 
community themselves (figure 3), while seafood was the 
second most important source for CTX-M-15 (10%) and 
CTX-M-27 (10%). Approximately 45% of CTX-M-1 
occurrences were attributed to the carriers in the open 
community, followed by dogs (10%), and bovine meat 
(9%) and chicken meat (9%; figure 3). SHV-12 and 
CMY-2 were mainly attributed to the carriers in the open 
community (41% for SHV-12 and 45% for CMY-2), 
followed by chicken meat (14% for SHV-12 and 14% for 
CMY-2). Posterior distributions for qi and aj are reported 
in the appendix (pp 5–6).
In our validation analyses, as anticipated, the model for 
non-typhoid salmonellosis (appendix p 13) including 
humans as a potential source estimated humans to have 
a very small contribution (0·054%, 95% CrI 0·001–0·233), 
supporting the hypothesis that the high resemblance in 
subtypes did not introduce an artifact into our main 
analysis. Moreover, the model in which the sources from 
the same reservoirs were grouped together provided 
comparable attributions (in terms of ranking, propor- 
tionality, and uncertainty) to those of the main analysis 
differentiating between animal and food sources 
(appendix p 14), showing that including animals and 
foods separately had no significant consequences.
The baseline ESBL-EC and pAmpC-EC prevalence 
of 5% and estimated 60·1% contribution of intra-
community transmission corresponded to an R0 of 0·63 
(95% CI 0·42–0·77). Additional structure with household 
clusters lowered the R0 (appendix pp 9–10); with up to 
50% of first acquisitions occurring within households, 
the effect of clustering was small.
Discussion
Prioritisation of interventions targeting potential sources 
of community-acquired ESBL-EC and pAmpC-EC carriage 
has often been based on prevalence and molecular data. 
Although highly informative, to our knowledge, no 
attempts have been made so far to quantify the 
contributions of different sources in a comparative way. 
Here, we showed that human-to-human transmission in 
the open community is estimated to have a greater impact 
than several putative sources of direct ESBL-EC and 
pAmpC-EC transmission, such as direct contact with farm 
and companion animals, some environmental sources, 
and consumption of meats, seafood, and raw vegetables. 
Our estimates arose from distinguishable patterns of 
ESBL-EC and pAmpC-EC gene occurrence in different 
sources.
Livestock, particularly poultry, did not appear to be the 
primary source of carriage. Poultry has had considerable 
attention due to its high ESBL-EC and pAmpC-EC 
prevalence,2 but its importance as a source for humans is 
debatable.6 Although parallel occurrence of ESBL and 
pAmpC genes, plasmids, or bacterial clones in poultry 
and humans has been considered as evidence of poultry 
being an important source of infection,2 previous 
whole-genome sequencing has not shown significant 
clonal transmission from poultry to humans via 
consumption of chicken meat.17 Yet, whole-genome 
sequencing did show the possibility of direct transmission 
between, for example, pigs and their caretakers via 
occupational exposure, and the predominance of 
identical ESBL-carrying IncI1-plasmids in cephalosporin-
resistant E coli suggested a prominent role of mobile 
Mean (95% CrI) Median SD
Human sources
Human-to-human transmission in the open community 60·1% (40·0–73·5) 61·3% 8·7
Secondary transmission from high-risk groups 6·9% (4·1–9·2) 6·9% 1·3
Returning travellers 3·9% (2·3–5·5) 3·9% 0·8
Clinical patients 2·0% (1·2–2·6) 2·0% 0·4
Poultry and pig farmers 1·0% (0·5–1·6) 1·0% 0·3
Food consumption and preparation 18·9% (7·0–38·3) 17·6% 8·1
Seafood 6·6% (0·3–21·6) 5·1% 5·8
Chicken meat 4·5% (0·2–13·1) 3·7% 3·5
Bovine meat 3·6% (0·1–12·5) 2·7% 3·3
Turkey meat 1·8% (0–6·1) 1·3% 1·6
Raw vegetables 1·1% (0–3·9) 0·8% 1·1
Pork 0·9% (0–3·3) 0·6% 0·9
Sheep or goat meat 0·4% (0–1·6) 0·3% 0·4
Animals
Contact with companion animals 7·9% (1·4–19·9) 7·0% 4·9
Dogs 5·1% (0·2–16·3) 3·9% 4·4
Cats 2·4% (0·1–8·0) 1·9% 2·2
Horses 0·5% (0–1·7) 0·3% 0·5
Non-occupational contact with farm animals 3·6% (0·6–9·9) 3·0% 2·5
Chickens 2·8% (0·1–9·0) 2·1% 2·4
Cattle 0·4% (0–1·4) 0·3% 0·4
Sheep or goats 0·3% (0–1·1) 0·2% 0·3
Pigs 0·1% (0–0·5) 0·1% 0·1
Environment 2·6% (0·2–8·7) 1·9% 2·3
Swimming in surface freshwater 2·3% (0·1–8·4) 1·6% 2·3
Contact with wild birds 0·3% (0–1·1) 0·2% 0·3
The percentage attributions of intestinal carriage of ESBL or pAmpC gene detections in E coli isolates from individuals of 
the open community (n=454) to the different human and non-human sources. ESBL=extended-spectrum β-lactamase. 
pAmpC=plasmid-mediated AmpC. CrI=credible interval.
Table: Estimated attributions of each considered source of intestinal carriage of ESBL or pAmpC 
gene-carrying Escherichia coli detected in the open community in the Netherlands, 2005–17
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genetic elements.17 Moreover, a previous analysis of 
molecular linkages in a large collection of ESBL-EC and 
pAmpC-EC isolates (which were included in our study) 
showed that ESBL-EC and pAmpC-EC gene distribution 
in the open community does not have a high level of 
similarity with livestock and food.7 Risk assessments 
have also shown that human exposure to ESBL-EC and 
pAmpC-EC via meat consumption and swimming in 
(Figure 3 continues on next page)
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Figure 3: ESBL and pAmpC 
gene-specific attributions for 
intestinal carriage of 
Escherichia coli in the open 
community
(A) Relative probabilities (%) 
for each ESBL-EC and 
pAmpC-EC gene in the open 
community originating from 
each source as estimated by 
the source attribution model; 
the number of occurrences for 
each gene is reported in 
figure 1. (B) Relative 
probabilities (%) for all 
ESBL-EC and pAmpC-EC genes 
in the open community 
originating from each source 
as estimated by the source 
attribution model, with the 
number of gene occurrences in 
the open community 
illustrated by the height of the 
row. ESBL=extended-spectrum 
β-lactamase. 
pAmpC=plasmid-mediated 
AmpC. ESBL-EC=ESBL-
producing E coli. pAmpC-
EC=pAmpC-producing E coli.
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surface freshwater is generally low.12,28 In a 2018 study,29 a 
large collection of E coli genomes (including ESBL-EC 
and pAmpC-EC) from livestock and retail meat in the UK 
were compared with those from bloodstream infections. 
Core-genome analysis showed that livestock and patient 
isolates were genetically distinct, and accessory genome 
analysis (ie, the genome containing genes that are not 
present in all strains of a species) identified a virulence 
cassette associated previously with cystitis and neonatal 
meningitis that was only present in humans. We also 
found little evidence that most ESBL-EC and pAmpC-EC 
in humans originated from livestock. Moreover, a Dutch 
study16 on household transmission of ESBL-producing 
bacteria suggested that, although no single dominant 
acquisition route in the community exists, the estimated 
probability of transmission from an index patient to a 
household contact is 67%. Studies of children have also 
shown that the only factors predicting carriage of 
ESBL-producing and pAmpC-producing bacteria were 
related to hygiene and cleaning practices,8,9 further 
indicating that anthroponotic transmission of ESBL-EC 
and pAmpC-EC contributes substantially to total trans-
missions. Our finding of a relatively large attributable 
fraction of ESBL-EC and pAmpC-EC recirculation in the 
open community led to a higher R0 than previously 
estimated.16,18 However, these previous estimates were 
only based on in-household transmission from patient or 
returning traveller index cases and ignored other modes 
of anthroponotic transmission. When adding clustering 
to such transmission (as increased human-to-human 
contact is expected to occur in, for example, households, 
workplaces, and schools), the R0 decreased, suggesting 
that our estimate was actually an upper bound. Moreover, 
we assumed ESBL-EC and pAmpC-EC prevalence to be 
at quasiequilibrium—ie, adapting reasonably fast to 
changes in source populations, which is supported by the 
lack of differences in resistance to third-generation and 
fourth-generation cephalosporins among Dutch clinical 
isolates in 2013–17.30 However, before this time period, 
prevalence showed periods of increase,30,31 so our R0 
estimate might be conservative. Because we could only 
attribute human ESBL-EC and pAmpC-EC to sources 
and not vice versa, hypothetically, the R0 in either group 
could be less than 1, whereas the R0 in the whole system 
could be more than 1, meaning that the leading 
transmission route is still anthroponotic, albeit not self-
maintaining without transmission to and from non-
human sources.
Herein, we only considered ESBL-EC and pAmpC-EC 
genes. These genes can be acquired horizontally through 
mobile genetic elements like plasmids, independently of 
cell division, in a variety of intestinal and extraintestinal 
environments. Thus, full understanding of ESBL-EC and 
pAmpC-EC spread depends on the characterisation of 
both ESBL and pAmpC genes and the plasmids carrying 
them, and the E coli sequence types. Human-adapted 
E coli variants, such as sequence type 131, which is often 
reported to carry CTX-M genes (especially CTX-M-15),12 
might then be more favourable for transmission than 
other strains. Other source attribution studies might 
therefore provide additional insights if they include 
plasmid data, and possibly sequence types too. Indeed, 
although different sources have different E coli popu-
lations, they might carry identical ESBLs and pAmpCs 
because of horizontal gene transfer via plasmids. 
Therefore, bacterial variants might be less important than 
plasmids for source attribution. Additionally, resistance 
genes can be transferred between the chromosome and 
Figure 4: Sankey diagram of the flow of ESBL and pAmpC genes found in Escherichia coli isolates in the open community to and from their attributable sources
The width of the coloured boxes and their connecting grey bands are directly proportional to the frequency of gene occurrence in the open community (left side) 
and flow quantities of these genes to the attributable sources (right side). Only sources with at least one full gene occurrence attributed to them are included. 
ESBL=extended-spectrum β-lactamase. pAmpC=plasmid-mediated AmpC. ESBL-EC=ESBL-producing E coli. pAmpC-EC=pAmpC-producing E coli.
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plasmids and between different plasmids, although some 
genes are associated with specific plasmid families and 
might therefore mirror one another.7 The resistance gene 
itself was therefore the most robust infective unit for this 
analysis.
The ESBL-EC and pAmpC-EC genes in the open 
community were obtained from large population-based 
studies in the Netherlands and were representative of the 
gene landscape in the Dutch general population.7 This 
approach implies that we also captured the full spectrum 
of individuals in the community, including those more 
susceptible to colonisation with, rather than more 
exposed to, ESBL-EC and pAmpC-EC because of 
underlying conditions, unless they were exposed to 
health-care settings, in which case they belonged to the 
clinical patient group and acted as potential source of 
secondary transmission for the open community. While 
an overall estimate of the relative contributions of the 
different sources to all the ESBL-EC and pAmpC-EC 
genes occurring in the open community was possible, 
variation in gene-specific attributions was substantial. 
Although our dataset was based on several studies 
that were subject to strict scrutiny to ensure 
representativeness, some heterogeneity in terms of 
spatiotemporality, study design, and analytical methods 
was present, as addressed and discussed in the previous 
publication of this dataset.7 Moreover, differentiating 
between imported and domestic foods or animals was not 
possible, and ESBL-EC and pAmpC-EC gene occurrences 
from sources like chickens, cattle, and meats were more 
exhaustively represented than sources like seafood, sheep 
and goats, and surface water. Molecular similarities in 
ESBL-EC and pAmpC-EC between humans and surface 
waters,7 while being suggestive of transmission, might 
also indicate a contribution of human wastewater to 
ESBL-EC and pAmpC-EC contamination in surface 
waters.32 Similarly, the ESBL-EC and pAmpC-EC genes in 
wild birds and fish and shellfish are usually exchanged 
through surface waters. Surface waters might therefore 
also act as a vector for local transmission between 
humans and animals. Nevertheless, the contribution of 
surface freshwater is seasonally dependent, as shown in 
the higher attribution during summer than across the 
whole year. We found ESBL-EC and pAmpC-EC to be 
quite prevalent in seafood, which is compelling because 
in the Netherlands several seafood products are regularly 
consumed raw, undercooked, cured, or smoked (eg, 
oysters, scallops, herrings, salmon, eel, sushi). Because 
fishery has received relatively little attention regarding 
ESBL-EC and pAmpC-EC, relies heavily on imports (also 
from areas where antimicrobial use in aquaculture is 
widespread), and mirrors the larger problem of 
antimicrobial resistance in surface waters, further studies 
in this area are advised. Similarly, further studies are 
recommended for raw vegetables contaminated via 
irrigation. ESBL-EC and pAmpC-EC prevalence and 
concentration in raw vegetables are low,33 although 
fashionable culinary trends like decorative sprouts and 
juices and smoothies might favour transmission. Both 
seafood and vegetables might be enriched with ESBL-EC 
and pAmpC-EC genes of human origin via human 
wastewater. Indeed, seafood is increasingly farmed in 
coastal aquacultures, close to surface freshwater sources 
and coastal run-off, which provide opportunities for 
accumulation of human-borne ESBL-EC and pAmpC-EC 
genes, especially in filter-feeding organisms. The same 
applies to surface freshwater-irrigated vegetables and 
swimming in surface freshwater. Thus, these sources are 
likely part of a larger human metacycle, whereby humans 
are re-infected with human-adapted ESBL-EC and 
pAmpC-EC. If this cycle were taken into account, we 
expect that the contribution of food to ESBL-EC and 
pAmpC-EC spread would be lower than estimated here. 
The same would also apply to companion animals; 
indeed, dogs and cats have dynamic ESBL-EC and 
pAmpC-EC shedding patterns and are a source in close 
vicinity to humans.5 Contact with farm animals, while 
posing a risk for those occupationally exposed,4 has a less 
important role in the open community owing to the low 
exposure levels.
We considered a broad spectrum of putative sources; 
however, our list was far from complete. No data were 
available for analysis for several animal, food, and 
environmental sources (eg, non-avian wildlife, pests, 
pets other than dogs and cats, dairy, cereals, seawater, 
different fomites, soil, dust, air). Hence, we might have 
overestimated the contribution of some of the considered 
sources, including the human ones. Moreover, data were 
not longitudinal in nature. Consequently, our calculated 
attributions are a snapshot of a situation that might 
change over time because carriage is temporal and the 
importance of some sources might fluctuate. We used an 
extensively applied source attribution model,22 with 
humans also included as sources, which is a deviation 
from the standard attribution framework for pathogens 
like Salmonella for which unidirectionality of trans-
mission (from animal, food, or environmental sources to 
humans, with humans as the endpoint) is always an 
assumption. This deviation allowed for the quantification 
of the anthroponotic contribution along side the non-
human sources, which were all potential sources of direct 
transmission, although we did not explicitly account for 
transmission cycles within or between sources. The 
modified Hald model is ecological in nature whereby 
populations are the unit of investigation, making it 
vulnerable to bias from large unrecognised outbreaks 
linked to a source, which undermine causal inference. 
However, ESBL-EC and pAmpC-EC are commensals, 
and although successful clonal expansions do happen, 
their epidemiology is different from that of pathogens 
like Salmonella, for which point-source outbreaks occur 
continuously. Moreover, the studies from which data 
for the open community were collected were cross-
sectional (not longitudinal surveillance data), excluded 
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recognised outbreaks, contained few household contacts 
(approximately 7%), and reported a high diversity of 
E coli sequence types where available,7 indicating that 
outbreaks were unlikely and supporting the hypothesis 
that the attributions reflected sporadically acquired 
ESBL-EC and pAmpC-EC.
ESBL-EC and pAmpC-EC occurrence is the result of 
several factors, including antibiotic use and misuse in 
humans and animals. Our analysis showed an important 
role of human-to-human trans mission, indicating that 
same-species transmission predominates, possibly due 
to increased chance of horizontal gene transfer or 
higher fitness of human-associated E coli strains 
carrying the ESBL and pAmpC genes in question. Yet, 
our analysis could not discern whether positive selection 
leading to emergence or spread of new variants of ESBL-
EC and pAmpC-EC genes in humans mainly takes place 
in non-human sources, or whether these genes are 
subsequently propagated in the open community after 
successful spillover. Indeed, continuous exposure to 
ESBL-EC and pAmpC-EC from non-human sources 
could be speculated to only sporadically result in 
successful transfer of ESBL and pAmpC genes to 
human-adapted E coli or other bacteria, or to successful 
adaptation (eg, to the human gut) of E coli strains 
carrying the ESBL or pAmpC genes in question. From a 
broader perspective, our finding of a relatively large 
fraction of community-acquired carriage of ESBL-EC 
and pAmpC-EC attri butable to anthroponotic sources is 
actually a reassuring finding, because with an R0 of less 
than 1 continuous growth is unlikely. This finding 
would also explain the relatively stable ESBL-EC and 
pAmpC-EC prevalence of approximately 5% that has 
been repeatedly measured across the past two decades 
in the Netherlands.8–12 To discern whether the non-
human sources might act as natural boosts (eg, new 
intro ductions, possibly from abroad) to revive the 
baseline prevalence (which might not maintain itself 
with only human-to-human transmission), we need 
time-dependent source attri bution analyses based on 
longitudinal data.
Although complex dynamics are involved in ESBL-EC 
and pAmpC-EC transmission, our results provide 
quantitative links between specific ESBL-EC and pAmpC-
EC genes in the open community and their probable 
human and non-human sources of direct transmission. 
Approximately two-thirds of community-acquired ESBL-
EC and pAmpC-EC carriers are attributable to human-to-
human transmission, with the considered non-human 
sources accounting for the other third. While anthro-
ponotic sources prevail, our findings underpin the need 
for longitudinal studies and warrant continuous 
monitoring in both human and non-human popu-
lations, because intracommunity ESBL-EC and pAmpC-
EC spread alone seems unlikely to be self-maintaining 
without transmission to and from non-human sources. 
Transmission routes of antibiotic resistance are complex, 
with numerous interconnected cycles and subcycles 
involving different hosts and environments. Because 
resistant bacteria might pass into humans from animals 
and food, and via environment-mediated and human-to-
human trans mission, a One Health approach is needed 
that values inter disciplinarity and stresses the 
connections between public, animal, and environmental 
health, and provides an integrated framework for 
improving our understanding of the global threat of 
antimicrobial resistance.
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